Proven Performance

Measured Outcomes Across
Specialty Service Lines

Delivering consistent, data-driven outcomes across every service line. Improve conversion from patient inquiry to scheduled consultation with a measured, multi-channel patient-access system.

Accountable
Patient-Access Performance

Accountable Patient-Access Performance

Patient Reach 360 delivers an average cost per qualified consult under $200, with some markets achieving as low as $100–$150 per qualified consult.

Our automated, multi-channel system supports the full patient journey through 8–10 touchpoints across calls, SMS, email, and reminders.

Real-time analytics track inquiry volume, qualification, conversions, response time, no-shows, geographic trends, insurance mix, and qualified consult performance—giving practices operational intelligence across the full patient-access funnel.

Patient Reach 360 uses an automated, multi-channel system to guide patients through the entire journey while providing real-time analytics that deliver clear visibility into lead performance, conversions, and overall operational efficiency.

<$200

Total Cost Per Qualified Consult

<$200

Total Cost Per Qualified Consult

13+ Service Lines

Scalable Growth Across Specialties

13+ Service Lines

Scalable Growth Across Specialties

13+ Service Lines

Scalable Growth Across Specialties

8-10 Touchpoints

Automated Conversion Workflow

8-10 Touchpoints

Automated Conversion Workflow

8-10 Touchpoints

Automated Conversion Workflow

Patient Re-engagement

& Continuity of Access

Patient Re-engagement

& Continuity of Access

Patient Re-engagement

& Continuity of Access

Market-Level Patient-Access Intelligence

Case Study

Vantage Vascular

Brooklyn, NY & Fair Lawn, NJ

60-Day Trial Performance

November 15, 2025 – January 15, 2026

Total Embolization Inquiries: ~600
Qualified Inquiries: ~300

Consultation &
Procedure Outcomes

43 Total Consults
Total Cost per Consult: ~$400

After filtering out non-candidates due to insurance mismatches, being outside the clinic’s service area, or not meeting other eligibility requirements, approximately 50% of the remaining patients met the established clinical qualification standards for further evaluation and potential treatment.

Post Trial Growth

Following the trial, Vantage narrowed its focus to Fibroids and Hemorrhoids and increased its advertising budget. After scaling, the practice generated 40+ additional scheduled procedures at a sub-$200 all-in acquisition cost per procedure, with inbound volume exceeding front office capacity

Dr. Vishal Sinha

Vantage Vascular

“That ‘try before you buy’ structure removed much of the risk we usually feel when bringing on a new vendor and quickly made it clear that they were creating real value for our group.”

— Dr. Vishal Sinha

Testimonials

What They Say About Us

Hear from practice leaders and industry partners.

Azhar Iqbal, MD

Medical Director, Buffalo Fibroid Clinic Vice President, Mid Atlantic OEIS

Kamal has been in the trenches and understands patient messaging that is pertinent and professional with conversion to consults when the patient is ready and comfortable.

Diane Keen

Vice President, Strategy and Growth, AbbaDox

The timing is right for this level of innovation and its potential to redefine how OBL's connect with patients and drive growth.

Testimonials

What They Say About Us

Hear from practice leaders and industry partners.

Azhar Iqbal, MD

Medical Director, Buffalo Fibroid Clinic Vice President, Mid Atlantic OEIS

Kamal has been in the trenches and understands patient messaging that is pertinent and professional with conversion to consults when the patient is ready and comfortable.

Diane Keen

Vice President, Strategy and Growth, AbbaDox

The timing is right for this level of innovation and its potential to redefine how OBL's connect with patients and drive growth.

Testimonials

What They Say About Us

Hear from practice leaders and industry partners.

Azhar Iqbal, MD

Medical Director, Buffalo Fibroid Clinic Vice President, Mid Atlantic OEIS

Kamal has been in the trenches and understands patient messaging that is pertinent and professional with conversion to consults when the patient is ready and comfortable.

Diane Keen

Vice President, Strategy and Growth, AbbaDox

The timing is right for this level of innovation and its potential to redefine how OBL's connect with patients and drive growth.

Join Specialty Practices Growing with PR360

Join Specialty Practices Growing with PR360

Join Specialty Practices Growing with PR360

Reported results reflect defined time periods, service lines, markets, and operational criteria. Results may vary based on specialty, geography, practice response time, clinical eligibility, provider capacity, payer considerations, and other factors. Patient Reach 360 does not guarantee a specific volume of inquiries, appointments, consultations, or procedures.